Directors of United Therapeutics awarded themselves a generous stock option plan without shareholder approval after shareholders rejected such plans twice, and after losing $72 million in 2008, shareholders say in Delaware Chancery Court.
Categories / Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.
Additional Reads
-
-
Texans head to the polls for high-stakes US Senate primary February 17, 2026